Abstract
AIMS: To study the incidence and management of appendicular malignancy in patients undergoing appendicectomy in a tertiary care hospital METHODS: A retrospective study including 1,275 patients who were admitted in JSS hospital, under surgery department, between September 2016 to September 2021. Patients were ≥ 16 years, any gender who presented with pain abdomen, abdominal distension, fever, vomiting, or mass per abdomen, diagnosed as appendicitis or appendicular mass. Patients underwent laparoscopic/open appendicectomy or right hemicolectomy, based on intraoperative ndings. The specimen was sent for histopathological examination and followed up for further management if required. RESULTS: Among 1275 patients who underwent appendicectomy either open or laparoscopy, following histopathological examination of all the appendicectomy specimens, appendicular malignancy was reported in 7 patients (0.53). All 7 patients had complaints of pain in the right iliac fossa. On examination, 71.4% had tenderness in the right iliac fossa. Most common preoperative provisional diagnosis was acute appendicitis (57.1%). 3 patients underwent laparoscopic appendicectomy, 1 open appendicectomy, and based on intraoperative ndings, 2 underwent right hemicolectomy, 1 resection and anastomosis with ileostomy as metastasis was present. Histopathologically, 2 patients were diagnosed with adenocarcinoma appendix, 2 with low grade appendiceal mucinous neoplasm, 2 with metastatic mucinous adenocarcinoma and 1 patient with neuroendocrine tumour of appendix CONCLUSION: Appendiceal tumors are uncommon, majority are comprised of epithelial neoplasms. Present with abdominal pain, manifest as acute appendicitis, or incidentally discovered in appendectomy specimens during histopathological evaluation. Imaging ndings are suggestive of acute appendicitis mostly. CT is used for staging of appendiceal tumors and subsequent follow up. In majority, appendicectomy will be sufcient, and some require right hemicolectomy. Cytoreductive surgery and intraperitoneal chemotherapy have improved the prognosis of patients with peritoneal disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have